First marijuana-derived prescription drug will cost $32,500 a year

Mercury News
By Sam Wood, Philadelphia InquirerAug 13, 2018, 9:00 am45 pts
A new marijuana-derived drug to treat rare forms of severe epilepsy in children will cost about $32,500 per patient, per year. Epidiolex, the first cannabis pharmaceutical to be approved by the U.S. Food and Drug Administration, contains the active ingredient cannabidiol (CBD). It does not contain psychoactive…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Canadian Cannabis Sales Bounced Again 66

Australian Publishers Face Legal Action for Cannabis Advertisements 51

Maryland Governor Issues 7,000 Cannabis Pardons 45

States attempt to quell hemp drink boom 21

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.